Related Experiment Video
Updated: Aug 5, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Turning over a New Leaf: Medical Cannabis in the Age of Legalization
Kristin Palladino1, Celeste Song2, Deborah Pierce1
1Department of Family Medicine, University of Rochester, 777 South Clinton Avenue, Rochester, NY 14620, USA.
Abstract:
As medical cannabis becomes more widely legalized, clinicians face growing pressure to advise patients amid limited, inconsistent evidence. This article explores the evolving role of cannabis in treating multiple conditions while highlighting known risks like psychosis, cannabinoid hyperemesis syndrome, and cannabis use disorder. Attention is given to drug-drug interactions, challenges in clinical decision making, and racial disparities. With appropriate screening, monitoring, and clinician education, cannabis may serve as a valuable adjunct in patient-centered harm reduction care but demands thoughtful and evidence-informed use.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Induced Pluripotent Stem Cells
Somatic cells are...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Standards of Care II
